On the significance of germline cytogenetic rearrangements at MYCN locus in neuroblastoma

Molecular Cytogenetics

Volumn 6, Issue 1, 2013, Pages

  Lipska, Beata S ^a   Koczkowska, Magdalena ^a   Wierzba, Jolanta ^a   Ploszynska, Anna ^a   Iliszko, Mariola ^a   Izycka Swieszewska, Ewa ^b   Adamkiewicz Drozynska, Elzbieta ^a   Limon, Janusz ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b Laboratory of Pathology and Neuropathology   (Poland)

Author keywords

FRA2C; MYCN; Neuroblastoma; Partial 2p trisomy

Indexed keywords

ARTICLE; CARCINOGENESIS; CASE REPORT; CHILD; CHROMOSOME 18Q; CHROMOSOME 2P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME FRAGILE SITE; COMPARATIVE GENOMIC HYBRIDIZATION; CONGENITAL CANCER; CYTOGENETICS; GAIN OF FUNCTION MUTATION; GENE LOCATION; GENE LOCUS; GENE REARRANGEMENT; GENETIC LINKAGE; GERM LINE; HUMAN; LOSS OF FUNCTION MUTATION; MALE; MICROARRAY ANALYSIS; MYCN ONCOGENE; NEUROBLASTOMA; ONCOGENE; PARTIAL TRISOMY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE GENETICS; SCHOOL CHILD;

EID: 84885444887     PISSN: None     EISSN: 17558166     Source Type: Journal    
DOI: 10.1186/1755-8166-6-43     Document Type: Article

References (24)

1. Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project. Schleiermacher G, Mosseri V, London WB, Maris JM, Brodeur GM, Attiyeh E, Haber M, Khan J, Nakagawara A, Speleman F, Noguera R, Tonini GP, Fischer M, Ambros I, Monclair T, Matthay KK, Ambros P, Cohn SL, Pearson AD, Br J Cancer 2012 107 1418 1422 10.1038/bjc.2012.375 22976801
2. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma. White PS, Thompson PM, Gotoh T, Okawa ER, Igarashi J, Kok M, Winter C, Gregory SG, Hogarty MD, Maris JM, Brodeur GM, Oncogene 2005 24 2684 2694 10.1038/sj.onc.1208306 15829979 (Pubitemid 40593096)
3. The genetic landscape of high-risk neuroblastoma. Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, Carter SL, Cibulskis K, Hanna M, Kiezun A, Kim J, Lawrence MS, Lichenstein L, McKenna A, Pedamallu CS, Ramos AH, Shefler E, Sivachenko A, Sougnez C, Stewart C, Ally A, Birol I, Chiu R, Corbett RD, Hirst M, Jackman SD, Kamoh B, Khodabakshi AH, Krzywinski M, Lo A, et al. Nat Genet 2013 doi: 10.1038/ng.2529
4. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Janoueix-Lerosey I, Lequin D, Brugieres L, Ribeiro A, de Pontual L, Combaret V, Raynal V, Puisieux A, Schleiermacher G, Pierron G, Valteau-Couanet D, Frebourg T, Michon J, Lyonnet S, Amiel J, Delattre O, Nature 2008 455 967 970 10.1038/nature07398 18923523
5. Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma. Deyell RJ, Attiyeh EF, Cancer Genet 1988 204 113 121
6. MYCN in neuronal tumours. Schwab M, Cancer Lett 2004 204 179 187 10.1016/S0304-3835(03)00454-3 15013217 (Pubitemid 38167721)
7. European Cytogeneticists Association Register of Unbalanced Chromosome Aberrations (ECARUCA); an online database for rare chromosome abnormalities. Feenstra I, Fang J, Koolen DA, Siezen A, Evans C, Winter RM, Lees MM, Riegel M, de Vries BB, Van Ravenswaaij CM, Schinzel A, Eur J Med Genet 2006 49 279 291 10.1016/j.ejmg.2005.10.131 16829349 (Pubitemid 43994552)
8. Database of chromosomal imbalance and phenotype in humans using ensembl resources. Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, Rajan D, Van Vooren S, Moreau Y, Pettett RM, Carter NP DECIPHER, Am J Hum Genet 2009 84 524 533 10.1016/j.ajhg.2009.03.010 19344873
9. Neuroblastoma in a pediatric patient with a microduplication of 2p involving the MYCN locus. van Mater D, Knelson EH, Kaiser-Rogers KA, Armstrong MB, Am J Med Genet 2013 161 605 610 10.1002/ajmg.a.35766
10. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK, INRG Task Force, J Clin Oncol 2009 10 289 297
11. A case of partial 2p trisomy with neuroblastoma. Nagano H, Kano Y, Kobuchi S, Kajitani T, Jinrui Idengaku Zasshi 1980 25 39 45 10.1007/BF01876544 7401378 (Pubitemid 10093844)
12. Germline duplication of chromosome 2p and neuroblastoma. Patel JS, Pearson J, Willatt L, Andrews T, Beach R, Green A, J Med Genet 1997 34 949 951 10.1136/jmg.34.11.949 9391895 (Pubitemid 27480955)
13. Neuroblastoma in a dysmorphic girl with a partial duplication of 2p caused by an unbalanced translocation. Yuksel A, Seven M, Karaman B, Yilmaz S, Deviren A, Hacihanefioglu S, Basaran S, Clin Dysmorphol 2002 11 39 42 10.1097/00019605-200201000-00008 11822704 (Pubitemid 34088058)
14. Metachronous neuroblastoma in an infant with constitutional unbalanced translocation t(2;16)(p23; p13.3) involving ALK. Soh SY, Stavropoulos D, Bowdin S, Thorner P, Baruchel S, Malkin D, Meyn MS, Irwin M, Poster presentation at ANR Stockholm 2010 POC38
15. Congenital neuroblastoma in a patient with partial trisomy of 2p. Dowa Y, Yamamoto T, Abe Y, Kobayashi M, Hoshino R, Tanaka K, Aida N, Take H, Kato K, Tanaka Y, Ariyama J, Harada N, Matsumoto N, Kurosawa K, J Pediatr Hematol Oncol 2006 28 379 382 10.1097/00043426-200606000-00011 16794507 (Pubitemid 43970395)
16. Mechanisms for recurrent and complex human genomic rearrangements. Liu P, Carvalho CMB, Hastings PJ, Lupski JR, Curr Opin Genet Dev 2012 22 211 220 10.1016/j.gde.2012.02.012 22440479
17. Chromothripsis and cancer: causes and consequence of chromosome shattering. Forment JV, Kaidi A, Jackson SP, Nature Rev Cancer 2012 12 663 670
18. Constitutional chromothripsis rearrangements involve clustered double-stranded DNA breaks and nonhomologous repair mechanisms. Kloosterman WP, Tavakoli-Yaraki M, van Roosmalen MJ, van Binsbergen E, Renkens I, Duran K, Ballarati L, Vergult S, Giardino D, Hansson K, Ruivenkamp CA, Jager M, van Haeringen A, Ippel EF, Haaf T, Passarge E, Hochstenbach R, Menten B, Larizza L, Guryev V, Poot M, Cuppen E, Cell Rep 2012 1 648 655 10.1016/j.celrep.2012.05.009 22813740
19. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Molenaar JJ, Koster J, Zwijnenburg DA, van Sluis P, Valentijn LJ, van der Ploeg I, Hamdi M, van Nes J, Westerman BA, van Arkel J, Ebus ME, Haneveld F, Lakeman A, Schild L, Molenaar P, Stroeken P, van Noesel MM, Ora I, Santo EE, Caron HN, Westerhout EM, Versteeg R, Nature 2012 483 589 593 10.1038/nature10910 22367537
20. Gene amplification as double minutes or homogeneously staining regions in solid tumors: origin and structure. Storlazzi CT, Lonoce A, Guastadisegni MC, Trombetta D, D'Addabbo P, Daniele G, L'Abbate A, Macchia G, Surace C, Kok K, Ullmann R, Purgato S, Palumbo O, Carella M, Ambros PF, Rocchi M, Genome Res 2010 20 1198 1206 10.1101/gr.106252.110 20631050
21. The FRA2C common fragile site maps to the borders of MYCN amplicons in neuroblastoma and is associated with gross chromosomal rearrangements in different cancers. Blumrich A, Zapatka M, Brueckner LM, Zheglo D, Schwab M, Savelyeva L, Hum Mol Genet 2011 20 1488 1501 10.1093/hmg/ddr027 21258086
22. Constiutive fragile sites and cancer. Yunis JJ, Soreng A, Science 1984 226 1199 1204 10.1126/science.6239375 6239375
23. The molecular basis of common and rare fragile sites. Schwartz M, Zlotorynski E, Kerem B, Cancer Lett 2005 232 13 26 16236432 (Pubitemid 43054977)
24. A simple salting out procedure for extracting DNA from human nucleated cells. Miller SA, Dykes DD, Polesky HF, Nucleic Acids Res 1988 16 1215 10.1093/nar/16.3.1215 3344216